# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-036764
Filing Date
2026-08-10
Accepted
2026-08-10 09:00:37
Documents
57
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1274778
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 18528
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 18188
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 8411
5 | EX-32.2 | ex32-2.htm | EX-32.2 | 8739
| Complete submission text file | 0001493152-26-036764.txt |  | 6163750

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | maia-20260630.xsd | EX-101.SCH | 39231
7 | XBRL CALCULATION FILE | maia-20260630_cal.xml | EX-101.CAL | 40341
8 | XBRL DEFINITION FILE | maia-20260630_def.xml | EX-101.DEF | 163312
9 | XBRL LABEL FILE | maia-20260630_lab.xml | EX-101.LAB | 371061
10 | XBRL PRESENTATION FILE | maia-20260630_pre.xml | EX-101.PRE | 291403
60 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1005333

Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41455 | Film No.: 261256442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)